CO5170426A1 - Fortalecedor en polvo para leche humana - Google Patents

Fortalecedor en polvo para leche humana

Info

Publication number
CO5170426A1
CO5170426A1 CO00025252A CO00025252A CO5170426A1 CO 5170426 A1 CO5170426 A1 CO 5170426A1 CO 00025252 A CO00025252 A CO 00025252A CO 00025252 A CO00025252 A CO 00025252A CO 5170426 A1 CO5170426 A1 CO 5170426A1
Authority
CO
Colombia
Prior art keywords
human milk
weight
enhancer
strengthening powder
amount
Prior art date
Application number
CO00025252A
Other languages
English (en)
Inventor
Barrett-Reis Bridget
Patricia A Reynolds
Michael B Montalto
Connor Deborah L O
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22435984&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO5170426(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of CO5170426A1 publication Critical patent/CO5170426A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/206—Colostrum; Human milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/04—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk fats but no non-milk proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Un fortalecedor en polvo de leche humana que comprende:a. un componente de proteína presente en una cantidad de cerca del 24% por peso a cerca del 55% por peso del fortalecedor en polvo de leche humana,b. un componente graso presente en una cantidad de cerca del 1% por peso a cerca del 30% por peso del fortalecedor en polvo de leche humana, yc. un componente carbohidrato presente en una cantidad de cerca del 15% por peso a cerca del 75% por peso del fortalecedor en polvo de leche humana.
CO00025252A 1999-04-09 2000-04-06 Fortalecedor en polvo para leche humana CO5170426A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12857599P 1999-04-09 1999-04-09

Publications (1)

Publication Number Publication Date
CO5170426A1 true CO5170426A1 (es) 2002-06-27

Family

ID=22435984

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00025252A CO5170426A1 (es) 1999-04-09 2000-04-06 Fortalecedor en polvo para leche humana

Country Status (20)

Country Link
US (3) US6294206B1 (es)
EP (1) EP1168929B2 (es)
JP (2) JP4755762B2 (es)
CN (1) CN1353577A (es)
AR (1) AR023414A1 (es)
AT (1) ATE298200T1 (es)
AU (1) AU770601B2 (es)
BR (1) BR0007084A (es)
CA (1) CA2369007C (es)
CO (1) CO5170426A1 (es)
DE (1) DE60020945D1 (es)
ES (1) ES2243252T5 (es)
HK (1) HK1045082B (es)
IL (2) IL145395A0 (es)
MX (1) MX223614B (es)
NZ (1) NZ514164A (es)
PH (1) PH12000000861B1 (es)
SA (1) SA00210206B1 (es)
TW (1) TWI256881B (es)
WO (1) WO2000060949A2 (es)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294206B1 (en) * 1999-04-09 2001-09-25 Abbott Laboratories Powdered human milk fortifier
US6495599B2 (en) * 2000-04-13 2002-12-17 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses therof
US6716466B2 (en) * 2001-01-17 2004-04-06 Nestec S.A. Balanced food powder composition
US6620427B2 (en) * 2001-04-24 2003-09-16 Abbott Laboratories Method for improving bone mineralization
US20100268658A1 (en) * 2001-05-14 2010-10-21 Prolacta Bioscience Method for collecting, testing and distributing milk
US20070098863A1 (en) * 2005-09-23 2007-05-03 Prolacta Bioscience, Inc. Method for collecting, testing and distributing milk
US20070203802A1 (en) * 2005-09-23 2007-08-30 Prolacta Bioscience, Inc. Method for collecting, testing and distributing milk
US20020182243A1 (en) * 2001-05-14 2002-12-05 Medo Elena Maria Method of producing nutritional products from human milk tissue and compositions thereof
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US20060039958A1 (en) * 2003-05-28 2006-02-23 Monosolrx, Llc. Multi-layer films having uniform content
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
BR0307425A (pt) * 2002-02-04 2004-12-28 Bristol Myers Squibb Co Suplemento para leite humano
US20070009490A1 (en) * 2003-10-02 2007-01-11 Conte Anthony E Dried biotherapeutic composition, uses, and device and methods for administration thereof
WO2005034861A2 (en) * 2003-10-02 2005-04-21 The Bio Balance Corporation A dried biotherapeutic composition, uses, and device and methods for administration thereof
WO2005035557A2 (en) * 2003-10-14 2005-04-21 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Adenylate cyclase in the treatment and/or prophylaxis of immune-medicated disease
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
EP1637043A1 (en) * 2004-09-17 2006-03-22 Medela Holding AG Human milk fortifiers and methods for their production
AU2005282182A1 (en) * 2004-09-10 2006-03-16 Medela Holding Ag Human milk fortifiers and methods for their production
AU2005282183A1 (en) * 2004-09-10 2006-03-16 Medela Holding Ag Method for analysing and treating human milk and system therefore
EP1637880A1 (en) * 2004-09-17 2006-03-22 Medela Holding AG Method for analysing and treating human milk and system therefor
JP5160229B2 (ja) 2004-09-30 2013-03-13 モノソル・アールエックス・エルエルシー 均一の成分を有する多層フィルム
CA2537452C (en) 2005-03-09 2013-12-24 Abbott Laboratories Concentrated human milk fortifier liquid
US20060233915A1 (en) * 2005-04-15 2006-10-19 Bristol-Myers Squibb Company Liquid nutritional product to supplement human milk
WO2007035870A2 (en) * 2005-09-20 2007-03-29 Prolacta Bioscience, Inc. A method for testing milk
US20070118078A1 (en) * 2005-11-18 2007-05-24 Mcnally David J Method and apparatus for controlled feeding of an infant
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
CN101374509B (zh) * 2005-12-19 2013-06-19 雅培制药有限公司 β-羟基-β-甲基丁酸盐在制备用于治疗特征在于1-型和2-型细胞因子生成失衡的病症的药物中的应用
US20070243290A1 (en) * 2006-04-18 2007-10-18 Melody Thompson Method of tailoring infant formulas to individual nutritional needs prior to use
US9149052B2 (en) * 2006-08-30 2015-10-06 Prolacta Bioscience, Inc. Methods of obtaining sterile milk and compositions thereof
ES2894973T3 (es) * 2006-11-29 2022-02-16 Prolacta Bioscience Inc Composiciones de leche materna y métodos de preparación y uso de las mismas
ES2588527T3 (es) * 2006-12-08 2016-11-03 Prolacta Bioscience, Inc. Composiciones de lípidos humanos y procedimientos de preparación y utilización de los mismos
WO2008119163A1 (en) * 2007-03-29 2008-10-09 The Hospital For Sick Children Multi-nutrient milk fortifier
WO2008125428A2 (en) * 2007-04-16 2008-10-23 Unilever N.V. Edible emulsions with mineral
RU2475031C2 (ru) * 2007-05-18 2013-02-20 Мид Джонсон Нутришен Компани Подкисленная жидкая добавка к грудному молоку
JP2011507518A (ja) 2007-12-20 2011-03-10 アボット・ラボラトリーズ 安定な栄養粉末
PL2299837T3 (pl) * 2008-06-19 2017-08-31 Unilever N.V. Zawierające tłuszcz jadalne emulsje z żelazem i cynkiem
EA011075B1 (ru) * 2008-06-20 2008-12-30 Лев Михайлович МОГИЛЕВСКИЙ Сухая молочная смесь
JP2010126495A (ja) * 2008-11-28 2010-06-10 Morinaga Milk Ind Co Ltd 母乳添加用粉末
CN102300575A (zh) 2008-12-02 2011-12-28 普罗莱克塔生物科学公司 人乳渗透物组合物及其制备和使用方法
US9149452B2 (en) * 2009-04-20 2015-10-06 Women's & Children's Health Research Institute Inc. Methods and compositions for promoting the neurological development of an infant
WO2010134800A1 (en) * 2009-05-19 2010-11-25 N.V. Nutricia Human milk fortifier with high protein and long chain poly unsaturated fatty acids for improving body adipose tissue distribution
CA2785523A1 (en) 2010-01-29 2011-08-04 Abbott Laboratories Aseptically packaged nutritional liquids comprising hmb
MX2012008785A (es) 2010-01-29 2012-08-17 Abbott Lab Emulsiones nutricionales que comprenden beta-hidroxi-beta-metilbut irato (hmb) de calcio.
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
WO2011144221A1 (en) * 2010-05-18 2011-11-24 N.V. Nutricia Preterm milk formula
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液
EP2608681B1 (en) * 2010-08-24 2015-09-16 Abbott Laboratories Nutritional products having improved organoleptic properties
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
EP2488042B1 (en) * 2010-11-02 2013-10-02 Abbott Laboratories Stable concentrated liquid human milk fortifier
EP2658549B1 (en) * 2010-12-31 2020-06-03 Abbott Laboratories Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
EP2658547A1 (en) 2010-12-31 2013-11-06 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
CA2842672A1 (en) 2011-07-22 2013-01-31 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
DK2739157T3 (en) 2011-08-03 2018-01-08 Prolacta Bioscience Inc Microfiltration of human milk to reduce bacterial contamination
NL2007268C2 (en) * 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
BR112014004772A2 (pt) 2011-08-29 2017-03-21 Abbott Lab oligossacarídeos do leite humano para evitar danos e/ou promover a cura do trato gastrointestinal
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
EP2790522B1 (en) 2011-12-14 2015-06-03 Nestec S.A. Emulsified food product containing dairy protein
JP5878361B2 (ja) * 2011-12-20 2016-03-08 テルモ株式会社 栄養強化用粉末食品
EA201201023A1 (ru) * 2012-08-10 2013-02-28 Лев Михайлович МОГИЛЕВСКИЙ Быстрорастворимый молочный напиток
US20140057014A1 (en) * 2012-08-27 2014-02-27 Carol Lynn Berseth Formula Fortifier
EA020388B1 (ru) * 2012-10-01 2014-10-30 Ооо "Фармацевтическая Компания "Славянская Аптека" Фармацевтический состав, содержащий натрий, кальций, железо, цинк и обладающий метаболическим, противокатарактным, ретинопротекторным действием (варианты)
EA020389B1 (ru) * 2012-10-01 2014-10-30 Ооо "Фармацевтическая Компания "Славянская Аптека" Фармацевтический состав, содержащий натрий, железо, цинк и обладающий метаболическим, противокатарактным, ретинопротекторным действием (варианты)
JP6080508B2 (ja) * 2012-11-07 2017-02-15 テルモ株式会社 術後食
EP3821713A1 (en) 2013-03-13 2021-05-19 Prolacta Bioscience, Inc. High fat human milk products
RU2685187C2 (ru) * 2013-11-29 2019-04-16 Нестек С.А. Жидкая композиция обогатителя молока с относительно высоким содержанием липидов
SG11201704161YA (en) 2014-11-25 2017-06-29 Abbott Lab Method of improving visual processing, visual acuity, or both by administering compositions comprising rrr-alpha-tocopherol and carotenoid to infants
EP3240429A4 (en) * 2014-12-30 2018-12-05 Prolacta Bioscience, Inc. Methods of preventing and treating bronchopulmonary dysplasia using high fat human milk products
CA3009667C (en) * 2015-12-30 2024-03-26 Prolacta Bioscience, Inc. Human milk products useful in pre- and post-operative care
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
EP3452023A1 (en) 2016-05-05 2019-03-13 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
WO2019106147A1 (en) * 2017-12-01 2019-06-06 Nestec S.A. Human milk fortifier composition
JP2021523687A (ja) * 2018-05-22 2021-09-09 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 栄養組成物
AU2020200778A1 (en) * 2019-02-07 2020-08-27 Aggarwal, Rakesh Kumar A dry powdered human milk fortifier
AU2020225089A1 (en) 2019-02-22 2021-09-23 Aquero Canada Ltd. Fortified milk compositions and their processes of preparation
US20200282135A1 (en) * 2019-03-07 2020-09-10 Kpr U.S., Llc Delivery of fluid from a syringe
WO2021146561A1 (en) * 2020-01-17 2021-07-22 Prolacta Bioscience, Inc. Feeding protocol for optimal growth of preterm infants
CN111807598B (zh) * 2020-06-18 2022-03-11 西南科技大学 一种电场协同磷尾矿无害化处理电解锰渣渗滤液的方法
EP4042875A1 (en) * 2021-02-15 2022-08-17 Rakesh Kumar Aggarwal A human milk fortifier
WO2022200526A1 (de) * 2021-03-24 2022-09-29 Ammeva Gmbh Getrocknete frauenmilch zum einsatz als nahrungsergänzungsmittel, lebensmittel für besondere medizinische zwecke und als alleinnahrungsmittel für säuglinge

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD228951A3 (de) * 1982-12-02 1985-10-23 Inst Getreideverarbeitung Verfahren zur herstellung von granulierter nahrung
GB2142518B (en) * 1983-06-16 1987-12-09 Glaxo Group Ltd Infant foods
DE3570610D1 (en) * 1984-08-23 1989-07-06 Henkel Kgaa Method for making surfaces slip-proof
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
JP2516794B2 (ja) * 1988-02-26 1996-07-24 雪印乳業株式会社 ビタミンｄ代謝産物を配合した育児用調製乳
US5013569A (en) 1990-05-21 1991-05-07 Century Laboratories, Inc. Infant formula
JP3247206B2 (ja) * 1993-06-11 2002-01-15 明治乳業株式会社 ミルク組成物
US6136858A (en) * 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
CA2201931C (en) * 1994-10-05 2004-08-10 Gerhard Kohn Mixture of phospholipid-containing fats and lcp fatty acids
AU692612B2 (en) 1994-10-14 1998-06-11 Morinaga Milk Industry Company Limited Peptide mixture and products thereof
JPH09131163A (ja) * 1995-11-09 1997-05-20 Miyoshi Oil & Fat Co Ltd レシチンを含有する粉末
JP3920969B2 (ja) * 1997-08-04 2007-05-30 雪印乳業株式会社 栄養組成物
US6294206B1 (en) * 1999-04-09 2001-09-25 Abbott Laboratories Powdered human milk fortifier

Also Published As

Publication number Publication date
TWI256881B (en) 2006-06-21
CA2369007A1 (en) 2000-10-19
AU770601B2 (en) 2004-02-26
ATE298200T1 (de) 2005-07-15
AU4212500A (en) 2000-11-14
WO2000060949A2 (en) 2000-10-19
DE60020945D1 (de) 2005-07-28
PH12000000861B1 (en) 2006-11-21
MXPA01010013A (es) 2002-05-06
JP2011172569A (ja) 2011-09-08
ES2243252T5 (es) 2012-05-23
HK1045082A1 (en) 2002-11-15
HK1045082B (zh) 2006-04-21
US6472003B2 (en) 2002-10-29
CN1353577A (zh) 2002-06-12
JP2002540806A (ja) 2002-12-03
EP1168929A2 (en) 2002-01-09
US20020031576A1 (en) 2002-03-14
EP1168929B2 (en) 2012-01-18
BR0007084A (pt) 2002-09-10
SA00210206B1 (ar) 2005-11-23
MX223614B (es) 2004-10-18
US20030021868A1 (en) 2003-01-30
US6294206B1 (en) 2001-09-25
WO2000060949A3 (en) 2001-03-01
JP4755762B2 (ja) 2011-08-24
ES2243252T3 (es) 2005-12-01
NZ514164A (en) 2003-03-28
AR023414A1 (es) 2002-09-04
IL145395A (en) 2010-05-31
EP1168929B1 (en) 2005-06-22
CA2369007C (en) 2009-09-29
IL145395A0 (en) 2002-06-30

Similar Documents

Publication Publication Date Title
CO5170426A1 (es) Fortalecedor en polvo para leche humana
ATE324800T1 (de) Primärzusammensetzung enthaltend einen lipophilen,bioaktiven stoff
BR0106681A (pt) Fórmula pediátrica e métodos para prover nutrição a pacientes pediátricos e para melhorar tolerância em pacientes pediátricos
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
PT1207756E (pt) Utilizacao de espinosade ou de uma formulacao que compreende espinosade
Pani et al. Extrinsic tooth staining potential of high dose and sustained release iron syrups on primary teeth
DE60330542D1 (de) Pharmazeutische Zubereitung enthaltend einen NMDA Rezeptor Agonisten für die Behandlung von Bewegungsstörungen
MXPA02004933A (es) Composiciones cosmeticas conteniendo extracto de garbanzo y retinoides.
ES2195902T3 (es) Composicion que comprende esfingomielinasa alcalina para uso como preparacion dietetica, complemento alimenticio o producto farmaceutico.
ES2162586A1 (es) Composicion que comprende aceites ozonizados y/o otros productos naturales y/o sinteticos ozonizados, y su empleo en composiciones farmaceuticas, cosmeticas, dieteticas o de suplementos alimentarios, en los campos humano y veterinario
AR098251A2 (es) Uso de aivlosin o de una sal de adición ácida del mismo farmacológicamente aceptada para la preparación de un medicamento de uso veterinario, un alimento para aves de corral o cerdos, una composición recubierta estable para ser agregada a dicho alimento y un medicamento de uso veterinario
UA84270C2 (ru) Жидкая фармацевтическая композиция для орального применения, которая содержит связанный с ионообменной смолой прадофлоксацин и структурно-вяжущие гелеобразователи
AR026491A1 (es) Composiciones cosmeticas que contienen extracto de semillas de anis en combinacion con retinoides
IT1269185B (it) Associazione dotata di effetto sinergico che ha un effetto antagonista dei recettori nk1 e nk2
FR2801218B1 (fr) Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
RU2007147328A (ru) Ускоритель рекальцинирования зубной эмали и композиция для ухода за полостью рта, и содержащие его пищевой продукт или напиток
EA202090722A1 (ru) Препарат, наносимый на поверхности полости рта, для предотвращения заболеваний, приобретаемых через полость рта и глотку
EA200701091A1 (ru) Противозачаточный фармацевтический препарат
ES2029337T3 (es) Dentrifico con indicador de tiempo de cepillado.
BR0316135A (pt) Uso de um produto alimentìcio cozido
TR199802496T2 (xx) Konjestif kalp yetmezli�ini tedavi i�in form�lasyon.
BR0212289A (pt) Anticorpos contra caspase-8, preparação e uso do mesmo
DK1061938T3 (da) Orale sammensætninger med cytotoksiske proteiner i lav dosis
DE69802518T2 (de) Feste zusammensetzungen für orale verabreichung die l-carnitin- oder alkanoyl-l- carnitin-cholin-tartrat enthalten
BR9706976A (pt) Pasta anti-helmìntica

Legal Events

Date Code Title Description
FC Application refused